🇺🇸 FDA
Patent

US 11273167

Compositions and methods for modulating ABHD2 activity

granted A61KA61K31/58A61K31/66

Quick answer

US patent 11273167 (Compositions and methods for modulating ABHD2 activity) held by The Regents of the University of California expires Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/58, A61K31/66, A61K31/713, A61K38/465